IN2014MN02029A - - Google Patents
Info
- Publication number
- IN2014MN02029A IN2014MN02029A IN2029MUN2014A IN2014MN02029A IN 2014MN02029 A IN2014MN02029 A IN 2014MN02029A IN 2029MUN2014 A IN2029MUN2014 A IN 2029MUN2014A IN 2014MN02029 A IN2014MN02029 A IN 2014MN02029A
- Authority
- IN
- India
- Prior art keywords
- orally disintegrating
- disintegrating tablet
- 33provided
- palatable
- mouth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012098770 | 2012-04-24 | ||
| PCT/JP2013/061936 WO2013161823A1 (ja) | 2012-04-24 | 2013-04-23 | 口腔内崩壊錠及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02029A true IN2014MN02029A (enExample) | 2015-08-14 |
Family
ID=49483132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2029MUN2014 IN2014MN02029A (enExample) | 2012-04-24 | 2013-04-23 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9827200B2 (enExample) |
| EP (1) | EP2842549B1 (enExample) |
| JP (4) | JP6066351B2 (enExample) |
| KR (1) | KR101943686B1 (enExample) |
| CN (2) | CN106913553A (enExample) |
| BR (1) | BR112014026292B1 (enExample) |
| CA (1) | CA2870868C (enExample) |
| ES (1) | ES2694224T3 (enExample) |
| IN (1) | IN2014MN02029A (enExample) |
| TW (1) | TWI572371B (enExample) |
| WO (1) | WO2013161823A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015117999A1 (en) * | 2014-02-05 | 2015-08-13 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Orally disintegrating tablet formulations of memantine |
| EP3200772B1 (en) * | 2014-10-03 | 2022-08-03 | Novartis AG | Pharmaceutical compositions comprising alpelisib |
| JP5827428B1 (ja) * | 2015-01-15 | 2015-12-02 | 日新製薬株式会社 | テルミサルタン含有錠剤 |
| JP2016141630A (ja) * | 2015-01-30 | 2016-08-08 | 富士フイルム株式会社 | 口腔内崩壊錠 |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| CN108066304B (zh) * | 2016-11-16 | 2022-09-16 | 深圳万和制药有限公司 | 具有缓释性能的坦索罗辛口腔崩解片组合物 |
| TWI812602B (zh) | 2016-12-01 | 2023-08-21 | 日商第一三共股份有限公司 | 含二胺衍生物之口腔崩散錠及其製造方法 |
| JP7009288B2 (ja) * | 2017-05-18 | 2022-01-25 | エルメッド株式会社 | 湿製錠剤の製造方法及び湿製錠剤の品質向上方法 |
| JP7023186B2 (ja) * | 2017-05-29 | 2022-02-21 | 第一三共株式会社 | 認知症治療薬を含有する口腔内崩壊性錠剤 |
| JP7182356B2 (ja) * | 2017-07-05 | 2022-12-02 | 日本ケミファ株式会社 | 口腔内崩壊錠及びその製造方法 |
| JP7198575B2 (ja) * | 2017-07-11 | 2023-01-04 | キョーリンリメディオ株式会社 | メマンチン塩酸塩含有口腔内崩壊錠 |
| JP7148319B2 (ja) * | 2017-08-17 | 2022-10-05 | 第一三共株式会社 | プラスグレルを含む口腔内崩壊錠 |
| TWI795462B (zh) | 2017-11-17 | 2023-03-11 | 日商鹽野義製藥股份有限公司 | 光安定性及溶出性優異的醫藥製劑 |
| JP7360949B2 (ja) * | 2017-12-26 | 2023-10-13 | 東和薬品株式会社 | 環状口腔内崩壊錠 |
| JP7138666B2 (ja) * | 2018-01-24 | 2022-09-16 | 大原薬品工業株式会社 | γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
| CN110613691A (zh) * | 2018-06-19 | 2019-12-27 | 北京万全德众医药生物技术有限公司 | 一种含有peg-dspe-盐酸美金刚复合物的口崩片 |
| TWI826474B (zh) | 2018-06-27 | 2023-12-21 | 日商第一三共股份有限公司 | 包含二胺衍生物之顆粒劑、以及其用途及製造方法 |
| JP2020105173A (ja) * | 2018-12-27 | 2020-07-09 | 日本ケミファ株式会社 | ２種以上の薬物を含有する口腔内崩壊錠及びその製造方法 |
| CN109512790A (zh) * | 2018-12-28 | 2019-03-26 | 金日制药（中国）有限公司 | 一种口腔崩解片的处方及制备工艺 |
| WO2021095092A1 (ja) * | 2019-11-11 | 2021-05-20 | 大塚製薬株式会社 | 口腔内崩壊錠 |
| WO2022004871A1 (ja) * | 2020-07-03 | 2022-01-06 | あゆみ製薬株式会社 | 錠剤およびその製造方法 |
| JP7744908B2 (ja) * | 2020-07-27 | 2025-09-26 | 第一三共株式会社 | ミロガバリンベシル酸塩を含有する口腔内崩壊錠 |
| WO2022102457A1 (ja) * | 2020-11-10 | 2022-05-19 | 沢井製薬株式会社 | リナグリプチン含有口腔内崩壊錠 |
| CN115837012A (zh) * | 2021-01-18 | 2023-03-24 | 广州一品红制药有限公司 | 一种氨氯地平干混悬剂及其制备方法 |
| JP2022135317A (ja) * | 2021-03-05 | 2022-09-15 | 日医工株式会社 | リナグリプチン製剤 |
| CN113181125B (zh) * | 2021-04-27 | 2022-07-19 | 海南通用三洋药业有限公司 | 一种西他沙星片剂及其制备方法 |
| CN113332252A (zh) * | 2021-06-07 | 2021-09-03 | 大桐制药（中国）有限责任公司 | 一种洛索洛芬钠片的制备方法 |
| JP7210794B2 (ja) * | 2021-06-16 | 2023-01-23 | 日本ジェネリック株式会社 | リナグリプチン含有製剤及びリナグリプチン含有口腔内崩壊性錠剤 |
| CN113244238B (zh) * | 2021-06-16 | 2022-05-20 | 北京斯利安药业有限公司 | 含盐酸苯海索和叶酸的口崩片及其制备方法 |
| JP2023164069A (ja) * | 2022-04-28 | 2023-11-10 | 共和薬品工業株式会社 | ゾニサミド含有口腔内崩壊錠 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW391880B (en) * | 1994-01-31 | 2000-06-01 | Yamanouchi Pharma Co Ltd | An oral soluble type compression moulding and its preparation |
| JP4438121B2 (ja) | 1998-04-27 | 2010-03-24 | 大正製薬株式会社 | 口腔内速崩錠及びその製造方法 |
| JP2000273039A (ja) | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | 口腔内崩壊性組成物 |
| JP4551627B2 (ja) * | 2003-02-28 | 2010-09-29 | 東和薬品株式会社 | 口腔内崩壊錠剤の製造方法 |
| JP5584509B2 (ja) | 2003-02-28 | 2014-09-03 | 東和薬品株式会社 | 口腔内崩壊錠剤 |
| BRPI0411451A (pt) * | 2003-06-16 | 2006-07-18 | Allergan Inc | formas de dosagens orais de memantina |
| JP3841804B2 (ja) | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| CN101420982B (zh) * | 2006-04-13 | 2011-11-09 | 东亚药品株式会社 | 干式直压速崩片 |
| EP2050448A4 (en) | 2006-08-08 | 2012-01-04 | Kissei Pharmaceutical | Mouth-dropping tray with masked bitter taste and method of preparation |
| US20110053942A1 (en) * | 2008-02-13 | 2011-03-03 | Dainippon Sumitomo Pharma Co., Ltd. | Orally disintegrating tablets |
| JP2010070466A (ja) | 2008-09-16 | 2010-04-02 | Kyoto Pharmaceutical Industries Ltd | 口腔内崩壊錠 |
| JP5549443B2 (ja) | 2009-07-15 | 2014-07-16 | ライオン株式会社 | 口腔内崩壊錠及びその製造方法 |
| KR101767288B1 (ko) * | 2010-03-31 | 2017-08-10 | 모찌다 세이야쿠 가부시끼가이샤 | 복용 용이성 고형 제제 |
| JP5680898B2 (ja) | 2010-08-10 | 2015-03-04 | 京都薬品工業株式会社 | 苦味を抑制した速崩壊錠 |
| US9744134B2 (en) * | 2012-02-03 | 2017-08-29 | Asahi Kasei Chemicals Corporation | Orally disintegrating tablet containing bitterness-masking granules |
-
2013
- 2013-04-23 IN IN2029MUN2014 patent/IN2014MN02029A/en unknown
- 2013-04-23 CA CA2870868A patent/CA2870868C/en active Active
- 2013-04-23 WO PCT/JP2013/061936 patent/WO2013161823A1/ja not_active Ceased
- 2013-04-23 JP JP2014512615A patent/JP6066351B2/ja active Active
- 2013-04-23 KR KR1020147028967A patent/KR101943686B1/ko active Active
- 2013-04-23 CN CN201710256576.8A patent/CN106913553A/zh active Pending
- 2013-04-23 ES ES13781585.8T patent/ES2694224T3/es active Active
- 2013-04-23 US US14/395,428 patent/US9827200B2/en active Active
- 2013-04-23 EP EP13781585.8A patent/EP2842549B1/en active Active
- 2013-04-23 CN CN201380021692.1A patent/CN104244930A/zh active Pending
- 2013-04-23 BR BR112014026292-6A patent/BR112014026292B1/pt active IP Right Grant
- 2013-04-24 TW TW102114513A patent/TWI572371B/zh active
-
2016
- 2016-10-17 JP JP2016203530A patent/JP6325627B2/ja active Active
-
2018
- 2018-01-22 JP JP2018008108A patent/JP6545839B2/ja active Active
-
2019
- 2019-06-19 JP JP2019113467A patent/JP7028829B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101943686B1 (ko) | 2019-01-29 |
| US20150110880A1 (en) | 2015-04-23 |
| CN104244930A (zh) | 2014-12-24 |
| JP2018058910A (ja) | 2018-04-12 |
| JP6066351B2 (ja) | 2017-01-25 |
| CN106913553A (zh) | 2017-07-04 |
| JP2019151670A (ja) | 2019-09-12 |
| JPWO2013161823A1 (ja) | 2015-12-24 |
| JP6325627B2 (ja) | 2018-05-16 |
| CA2870868A1 (en) | 2013-10-31 |
| ES2694224T3 (es) | 2018-12-19 |
| HK1206983A1 (en) | 2016-01-22 |
| EP2842549B1 (en) | 2018-08-08 |
| KR20150003740A (ko) | 2015-01-09 |
| EP2842549A1 (en) | 2015-03-04 |
| JP6545839B2 (ja) | 2019-07-17 |
| WO2013161823A1 (ja) | 2013-10-31 |
| TW201347792A (zh) | 2013-12-01 |
| US9827200B2 (en) | 2017-11-28 |
| JP7028829B2 (ja) | 2022-03-02 |
| BR112014026292A2 (pt) | 2017-06-27 |
| JP2017008112A (ja) | 2017-01-12 |
| CA2870868C (en) | 2018-02-20 |
| TWI572371B (zh) | 2017-03-01 |
| EP2842549A4 (en) | 2015-09-23 |
| BR112014026292B1 (pt) | 2022-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USD675613S1 (en) | Tablet computer | |
| USD748812S1 (en) | Arched cell culture flask | |
| MY164904A (en) | Tobacco substrate | |
| PH12013500462A1 (en) | Gel composition | |
| PH12014500711A1 (en) | Seamless capsule and method of its production | |
| PH12012501699A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
| PH12013501222A1 (en) | Soluble milk-based tablet surface-treated with carbohydrate | |
| AU2013328639A8 (en) | Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture | |
| USD711718S1 (en) | Meter box grounding clamp | |
| MX2016009719A (es) | Sistema dispensador para productos de papel sanitario. | |
| TN2012000507A1 (en) | Enteric tablet | |
| WO2013166131A3 (en) | Orally disintegrating tablet | |
| MX2012008098A (es) | Proceso para la produccion de dioxido de cloro. | |
| MX2010002506A (es) | Compuestos de nicotinamida sustituidos y uso de estos en medicamentos. | |
| MY169160A (en) | Method for producing starch granules, and orally disintegrating tablet | |
| WO2010081722A3 (en) | Orally disintegrating tablets for the treatment of pain | |
| MY161968A (en) | Granules comprising pyrazosulfron ethyl and pretilachlor | |
| JP2015129124A5 (enExample) | ||
| PH12014501024A1 (en) | Soluble non-dairy creamer tablet surface-treated with carbohydrate | |
| ZA201403543B (en) | Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| USD744838S1 (en) | Container | |
| WO2012111961A3 (ko) | 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제 | |
| WO2010095840A2 (ko) | 도네페질 수지 착체 | |
| UA41304U (ru) | Кристаллическая структура комбинированного лекарственного препарата валсартану с гидрохлортиазидом в форме таблеток | |
| GEU20101592Y (en) | Anber tablet |